Protective effect of caffeic acid phenethyl ester against acute and subchronic mice cardiotoxicity induced by cyclophosphamide alone or plus naproxen

PM Emeka, MA Morsy, IA Alhaider… - Pharmacognosy …, 2020 - phcog.com
Background: The limiting factor in the use of cyclophosphamide (CYP) in cancer
chemotherapy is its induced oxidative cardiotoxicity. Objectives: This study aims to …
被引用次数：5 相关文章

Protective effect of caffeic acid phenethyl ester against acute and subchronic mice cardiotoxicity induced by cyclophosphamide alone or plus naproxen.

PM Emeka, MA Morsy, IA Alhaider, MS Chohan - 2020 - cabidigitallibrary.org
Background: The limiting factor in the use of cyclophosphamide (CYP) in cancer
chemotherapy is its induced oxidative cardiotoxicity. Objectives: This study aims to …

Protective effect of caffeic acid phenethyl ester against acute and subchronic mice cardiotoxicity induced by cyclophosphamide alone or plus naproxen.

P Emeka, M Morsy, I Alhaider… - Pharmacognosy …, 2020 - search.ebscohost.com
Background: The limiting factor in the use of cyclophosphamide (CYP) in cancer
chemotherapy is its induced oxidative cardiotoxicity. Objectives: This study aims to …

Protective effect of caffeic acid phenethyl ester against acute and subchronic mice cardiotoxicity induced by cyclophosphamide alone or plus naproxen.

P Emeka, M Morsy, I Alhaider, M Chohan - Pharmacognosy Magazine, 2020 - go.gale.com
Background: The limiting factor in the use of cyclophosphamide (CYP) in cancer
chemotherapy is its induced oxidative cardiotoxicity. Objectives: This study aims to …
[PDF] researchgate.net

[PDF][PDF] Protective Effect of Caffeic Acid Phenethyl Ester against Acute and Subchronic Mice Cardiotoxicity Induced by Cyclophosphamide Alone or Plus Naproxen

PM Emeka, MA Morsy, IA Alhaider, MS Chohan - 2020 - researchgate.net
Background: The limiting factor in the use of cyclophosphamide (CYP) in cancer
chemotherapy is its induced oxidative cardiotoxicity. Objectives: This study aims to …